drugset / Trial / NCT00975065
Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
RandomizedParallel-groupOpen-labelTreatment
Summary
The study design of this trial is open-label, randomized, multi-center, parallel-group study.
Timeline
- Start
- 2009-08
- Primary completion
- 2011-12
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 500 mg | — |
| Comparator | Metformin | Small molecule | 1000 mg | — |
| Comparator | Metformin | Small molecule | 1500 mg | — |
| Subject | Vildagliptin | Other / unclassified | 50 mg | Oral |